Attached files

file filename
8-K - FORM 8-K - GENTHERM Incd347525d8k.htm

Exhibit 99.1

 

LOGO

NEWS RELEASE for May 4, 2012 at 6:00 AM ET

 

Contact:    Allen & Caron Inc
   Jill Bertotti (investors)
   jill@allencaron.com
   Len Hall (media)
   len@allencaron.com
   (949) 474-4300

AMERIGON REPORTS 2012 FIRST QUARTER RESULTS

NORTHVILLE, MI (May 4, 2012) . . . Amerigon Incorporated (NASDAQ-GS: ARGN), a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications, today announced its financial results for the first quarter ended March 31, 2012.

On May 16, 2011, Amerigon closed the previously announced acquisition of a majority interest in W.E.T. Automotive Systems AG, a publicly-traded German automotive thermal control and electronic components company. The 2011 first quarter which was completed prior to the acquisition date does not include operating results of W.E.T.

President and CEO Daniel R. Coker said, “Revenues in the first quarter came in as we had projected. We are pleased with the progress made during the quarter and how things are looking for the future, particularly the resources and critical mass gained from the acquisition of W.E.T. In addition, the continuing success of our Climate Control SeatTM system (CCSTM) and the growing acceptance of our related products, including our new heated and cooled cup holders and our heated and cooled mattress products, and the progress our advanced development teams are making on our thermoelectric generators are all positive signs that bode well for our future.”

Revenues for the 2012 first quarter increased to $129.5 million from $35.8 million in the prior year period. The increase in revenues primarily reflects additional W.E.T. revenue of $100.5 million, including the positive effects of the first Amerigon vehicle program to be produced in a W.E.T. facility, which totaled $7.0 million. This year’s first quarter revenues were approximately 4 percent higher than the pro-forma combined results of both Amerigon and W.E.T. Had Amerigon acquired W.E.T. on January 1, 2011, pro-forma combined revenues during the 2011 first quarter would have been $124.5 million. Amerigon historical revenue for this year’s first quarter, as presented in an accompanying table, decreased 19 percent to $29.0 million from $35.8 million in the first quarter of 2011, due primarily to the program transfer to W.E.T.

This year’s first quarter net income attributable to common shareholders was $2.7 million, or $0.11 per basic and diluted share. Non-cash charges related to the W.E.T. acquisition totaled $1.9 million, or $0.08 per basic and diluted share. In addition, the 2012 first quarter results include convertible preferred stock dividends of $2.2 million, which reduced net income attributable to common shareholders by $0.09 per basic and diluted share. Adjusting for these


factors, Amerigon would have reported net income attributable to common shareholders of $0.28 per basic share and $0.27 per diluted share. Net loss attributable to common shareholders for the first quarter of 2011 was $666,000, or $0.03 loss per share, which included acquisition-related fees and expenses totaling $3.8 million. Excluding these charges, Amerigon would have earned $3.1 million, or $0.14 per basic share and $0.13 per diluted share, in the 2011 first quarter. The fees and expenses associated with the W.E.T. acquisition are detailed in the Acquisition Transaction Expenses, W.E.T. Purchase Accounting Impacts and Other Effects table accompanying the release.

Gross margin as a percentage of revenue for this year’s first quarter was 25 percent, compared with 29 percent in the first quarter of 2011 (for Amerigon alone). The decrease primarily reflects W.E.T.’s lower gross margin on sales (24.5 percent), and for Amerigon, lower sales volumes and an unfavorable mix of products sold.

Adjusted EBITDA for the first quarter of 2012 was $15.8 million compared with Adjusted EBITDA of $5.2 million for the prior year period, and was $1.0 million higher than Adjusted EBITDA during the fourth quarter 2011 of $14.8 million.

Historical Amerigon financial results and Adjusted EBITDA for the first quarter of 2012 (which are non-GAAP measures) are provided to help shareholders understand Amerigon’s results of operations due to the acquisition of W.E.T. These non-GAAP financial measures should be viewed in addition to, and not as an alternative for, Amerigon’s reported results prepared in accordance with GAAP.

On March 23, 2012, the Company completed a public offering of 5,290,000 shares of common stock, including the sale of 690,000 shares pursuant to the full exercise of the underwriters’ over-allotment option. Net proceeds to the Company from the sale of the shares including the over-allotment option were $75.5 million after the deduction of underwriting discounts and other offering expenses. The Company intends to use the net proceeds from this offering to make future redemption installment payments on, and pay dividends on, its outstanding Series C Convertible Preferred Stock totaling $49.9 million and, to the extent not used for such purposes, to fund debt service, debt retirement and general corporate purposes.

The Company’s balance sheet as of March 31, 2012, had total cash and cash equivalents, including the offering proceeds, of $100.6 million, total assets of $465.5 million and shareholders’ equity of $202.1 million. Total debt was $73.6 million, and the book value of the unredeemed Series C Convertible Preferred Stock was $43.5 million as of March 31, 2012.

Interest Expense and Revaluation of Derivatives

Interest expense for the first quarter of this year was $1.1 million compared with $9,000 in interest income for the prior year period. Approximately $442,000 in interest expense was related to the debt of W.E.T., and the balance resulted from financing used to fund a portion of the W.E.T. acquisition.

For this year’s first quarter, the Company recorded net gains related to the revaluation of derivative financial instruments totaling $1.4 million. The amount included net losses from the derivatives of W.E.T. Derivative gains and losses stem from W.E.T.’s Cash Related Swap (CRS) contract and portfolio of currency derivative instruments.


Research and Development, Selling, General and Administrative Expenses

The 2012 first quarter results include a year-over-year increase in net research and development expenses of $7.3 million reflecting net research and development expenses from W.E.T. totaling $7.4 million.

Selling, general and administrative (SG&A) expenses for this year’s first quarter increased $10.6 million primarily due to the SG&A expenses of W.E.T. totaling $9.9 million. Higher wage and benefit costs, consulting, audit and legal expenses also contributed to the increase. SG&A for the 2012 first quarter decreased $2.0 million sequentially from the 2011 fourth quarter primarily due to lower management bonus accruals and a lower foreign currency exchange rate on the Euro-denominated SG&A expenses of W.E.T.

Guidance

The Company expects combined revenues of Amerigon/W.E.T. in the 2012 second quarter to be moderately higher compared with the 2012 first quarter ($129.5 million) and in-line with the Company’s full year forecast. Barring unforeseen economic turbulence, 2012 appears to be a strong year for the combined companies. Amerigon is expecting revenue growth for the full year in the range of 10 percent over the combined Amerigon/W.E.T. 2011 revenues (which were $501.2 million on a full year pro-forma basis).

Conference Call

As previously announced, Amerigon is conducting a conference call today to be broadcast live over the Internet at 11:30 AM Eastern Time to review these financial results. The dial-in number for the call is 1-877-941-2068. The live webcast and archived replay of the call can be accessed in the Events page of the Investor section of Amerigon’s website at www.amerigon.com.

Note Regarding Use of Non-GAAP Financial Measures

Certain of the information set forth herein, including Adjusted EBITDA and historical Amerigon financial results, may be considered non-GAAP financial measures. Amerigon believes this information is useful to investors because it provides a basis for measuring Amerigon’s available capital resources, the operating performance of Amerigon’s business and Amerigon’s cash flow that would normally be included in the most directly comparable measures calculated and presented in accordance with Generally Accepted Accounting Principles. Amerigon’s management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measures in evaluating Amerigon’s operating performance, capital resources and cash flow. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP. Reconciliation between net income and EBITDA is provided in the financial tables at the end of this news release.

About Amerigon

Amerigon (NASDAQ-GS:ARGN) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products based on technologies developed by Amerigon and its majority-owned subsidiary, W.E.T. Automotive Systems AG, include actively heated and cooled seat systems and cup holders, heated and ventilated seat systems, thermal storage bins, heated seat and steering wheel systems, cable systems and other electronic devices. Its advanced technology team is developing more efficient materials for thermoelectrics and systems for waste heat recovery and electrical power generation for the automotive market that may have


far-reaching applications for consumer products as well as industrial and technology markets. Amerigon has more than 5,000 employees in facilities in the U.S., Germany, Mexico, China, Canada, Japan, England, Korea and the Ukraine. For more information, go to www.amerigon.com.

Certain matters discussed in this release are forward-looking statements that involve risks and uncertainties, and actual results may be different. Important factors that could cause the Company’s actual results to differ materially from its expectations in this release are risks that sales may not significantly increase, additional financing, if necessary, may not be available, new competitors may arise and adverse conditions in the automotive industry may negatively affect its results. The liquidity and trading price of its common stock may be negatively affected by these and other factors. Please also refer to Amerigon’s Securities and Exchange Commission filings and reports, including, but not limited to, its Form 10-Q for the period ended March 31, 2012, and its Form 10-K for the year ended December 31, 2011.

TABLES FOLLOW


AMERIGON INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

     Three Months Ended
March 31,
 
  
     2012     2011  

Product revenues

   $ 129,526      $ 35,796   

Cost of sales

     97,077        25,340   
  

 

 

   

 

 

 

Gross margin

     32,449        10,456   

Operating expenses:

    

Research and development

     10,201        2,661   

Research and development reimbursements

     (442     (192
  

 

 

   

 

 

 

Net research and development expenses

     9,759        2,469   

Acquisition transaction expenses

     —          3,754   

Selling, general and administrative

     13,973        3,364   
  

 

 

   

 

 

 

Total operating expenses

     23,732        9,587   
  

 

 

   

 

 

 

Operating income

     8,717        869   

Interest income (expense)

     (1,136     9   

Revaluation of derivatives

     1,360        —     

Foreign currency loss

     (511     —     

Other income

     79        227   
  

 

 

   

 

 

 

Earnings before income tax

     8,509        1,105   

Income tax expense

     2,244        1,771   
  

 

 

   

 

 

 

Net income

     6,265        (666

Gain (loss) attributable to non-controlling interest

     (1,387     —     
  

 

 

   

 

 

 

Net income attributable to Amerigon, Inc.

     4,878        (666

Convertible preferred stock dividends

     (2,165     —     
  

 

 

   

 

 

 

Net income (loss) attributable to common shareholders

   $ 2,713      $ (666
  

 

 

   

 

 

 

Basic earnings (loss) per share

   $ 0.11      $ (0.03
  

 

 

   

 

 

 

Diluted earnings (loss) per share

   $ 0.11      $ (0.03
  

 

 

   

 

 

 

Weighted average number of shares – basic

     24,461        22,081   
  

 

 

   

 

 

 

Weighted average number of shares – diluted

     25,151        22,081   
  

 

 

   

 

 

 

MORE-MORE-MORE


AMERIGON INCORPORATED

RESULTS EXCLUDING W.E.T.

The following table presents select operations data for the period as reported, amounts for W.E.T. operations and amounts for Amerigon less the W.E.T. amounts representing the historical portion of Amerigon. These Historical Amerigon financial results for the three-month period ended March 31, 2012, which are non-GAAP measures, are provided to help shareholders understand Amerigon’s results of operations in light of the acquisition of W.E.T. These non-GAAP financial measures should be viewed in addition to, and not as an alternative for, Amerigon’s reported results prepared in accordance with GAAP.

 

     Three-month period ended March 31, 2012     Three months ended
March 31, 2011
 
     As Reported     Less: W.E.T.     Historical Amerigon  
     (In Thousands)  

Product revenues

   $ 129,526      $ 100,528 1    $ 28,998      $ 35,796   

Cost of sales

     97,077        75,867        21,210        25,340   

Gross margin

     32,449        24,661        7,788        10,456   

Gross margin percent

     25.1     24.5     26.9     29.2

Operating expenses:

        

Net research and development expenses

     9,759        7,395        2,364        2,469   

Acquisition transaction expenses

     —          —          —          3,754   

Selling, general and administrative expenses

     13,973        9,944        4,029        3,364   

Operating income

     8,717        7,322        1,395        869   

Earnings before income tax

     8,509        7,789        720        1,105   

 

1 

Includes the positive effects of the first Amerigon vehicle program to be produced in a W.E.T. facility, which totaled $7.0 million.

MORE-MORE-MORE


Reconciliation of Adjusted EBITDA to Net Income

(Unaudited, in thousands)

 

     Three Months Ended
March 31,
 
     2012     2011  

Net income (loss)

   $ 6,265      $ (666

Add Back:

    

Income tax expense

     2,244        1,771   

Interest expense (income)

     1,136        (9

Depreciation and amortization

     7,319        390   

Adjustments:

    

Acquisition transaction expense

     —          3,754   

Unrealized currency (gain) loss

     1,524        (11

Unrealized revaluation of derivatives

     (2,666     —     
  

 

 

   

 

 

 

Adjusted EBITDA

   $ 15,822      $ 5,229   
  

 

 

   

 

 

 

Use of Non-GAAP Financial Measures

In evaluating its business, Amerigon considers and uses Adjusted EBITDA as a supplemental measure of its operating performance. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, and deferred financing cost amortization, less transaction expenses, debt retirement expenses, unrealized currency (gain) loss and unrealized revaluation of derivatives. Management believes that Adjusted EBITDA is a meaningful measure of liquidity and the Company’s ability to service debt because it provides a measure of cash available for such purposes. Management provides an Adjusted EBITDA measure so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company’s performance on a period-over-period basis.

The term Adjusted EBITDA is not defined under GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. Adjusted EBITDA has limitations as an analytical tool, and when assessing the Company’s operating performance, investors should not consider Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with GAAP. Amerigon compensates for these limitations by relying primarily on its GAAP results and using Adjusted EBITDA only supplementally.

MORE-MORE-MORE


AMERIGON INCORPORATED

ACQUISITION TRANSACTION EXPENSES, W.E.T. PURCHASE ACCOUNTING IMPACTS AND

OTHER EFFECTS

(In thousands, except per share data)

 

     Current Results               
     2012
3  months
    2011
3  months
     2012     2013     2014     Thereafter  
             

Transaction related current expenses

             

Acquisition transaction expenses

   $ —        $ 3,754       $ —        $ —        $ —        $ —     

Debt retirement expense

     —          —           —          —          —          —     
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 
   $ —        $ 3,754       $ —        $ —        $ —        $ —     
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Non-cash purchase accounting impacts

             

Customer relationships amortization

   $ 1,966      $ —         $ 7,865      $ 7,865      $ 7,865      $ 48,431   

Technology amortization

     824        —           3,298        3,298        3,298        9,506   

Product development costs amortization

     532        —           2,127        2,177        2,177        1,283   

Order backlog amortization

     —          —           —          —          —          —     

Inventory fair value adjustment

     —          —           —          —          —          —     
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 
   $ 3,322      $ —         $ 13,290      $ 13,340      $ 13,340      $ 59,220   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Tax effect

     (769     —           (3,078     (3,090     (3,090     (13,715

Net Income effect

     2,553        3,754         10,212        10,250        10,250        45,505   

Non-controlling interest effect

     (605     —           (2,436     (2,445     (2,445     (10,853
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Net income available to shareholders effect

   $ 1,948      $ 3,754       $ 7,776      $ 7,805      $ 7,805      $ 34,652   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (loss) per share—difference

             

Basic

   $ 0.08      $ 0.17            

Diluted

     0.08        0.16            

Series C Preferred Stock dividend

   $ 2,165      $ —         $ 6,711      $ 1,622      $ —        $ —     

Earnings (loss) per share—difference

             

Basic

   $ 0.09      $ —              

Diluted

     0.09        —              

MORE-MORE-MORE


AMERIGON INCORPORATED

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 

     March  31,
2012
    December  31,
2011
 
     (unaudited)        

ASSETS

    

Current Assets:

    

Cash & cash equivalents

   $ 100,601      $ 23,839   

Short-term investments

     —          —     

Accounts receivable, net of allowance

     89,905        82,395   

Inventory:

    

Raw Materials

     31,752        29,073   

Work in process

     2,343        2,497   

Finished goods

     16,125        14,774   
  

 

 

   

 

 

 

Inventory

     50,220        46,344   

Derivative financial instruments

     1,795        2,675   

Deferred income tax assets

     9,160        12,732   

Prepaid expenses and other assets

     11,440        9,685   
  

 

 

   

 

 

 

Total current assets

     263,121        177,670   

Property and equipment, net

     45,484        44,794   

Goodwill

     24,982        24,245   

Other intangible assets, net

     107,472        108,481   

Deferred financing costs

     2,250        2,441   

Deferred income tax assets

     12,675        11,402   

Other non-current assets

     9,555        8,774   
  

 

 

   

 

 

 

Total assets

   $ 465,539      $ 377,807   
  

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

Current Liabilities:

    

Accounts payable

   $ 43,402      $ 42,533   

Accrued liabilities

     51,489        46,293   

Current maturities of long-term debt

     15,309        14,570   

Derivative financial instruments

     3,507        5,101   

Deferred tax liabilities

     3,316        3,218   
  

 

 

   

 

 

 

Total current liabilities

     117,023        111,715   

Pension benefit obligation

     3,846        3,872   

Other liabilities

     1,926        1,862   

Long-term debt, less current maturities

     58,308        61,677   

Derivative financial instruments

     16,011        17,189   

Deferred tax liabilities

     22,839        23,679   
  

 

 

   

 

 

 

Total liabilities

     219,953        219,994   

Series C Convertible Preferred Stock

     43,450        50,098   

Shareholders’ equity:

    

Common Stock:

    

No par value; 55,000,000 shares authorized, 29,548,163 and 23,515,571 issued and outstanding at March 31, 2012 and December 31, 2011, respectively

     165,401     

 

80,502

  

Paid-in capital

     23,969        23,489   

Accumulated other comprehensive income (loss)

     (11,017     (14,754

Accumulated deficit

     (23,003     (25,716
  

 

 

   

 

 

 

Total Amerigon Incorporated shareholders’ equity

     155,350        63,521   

Non-controlling interest

     46,786        44,194   
  

 

 

   

 

 

 

Total shareholders’ equity

     202,136        107,715   
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 465,539      $ 377,807   
  

 

 

   

 

 

 

MORE-MORE-MORE


AMERIGON INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

     Three Months Ended March 31,  
             2012                     2011          

Operating Activities:

    

Net income

   $ 6,265      $ (666

Adjustments to reconcile net income to cash provided by operating activities:

    

Depreciation and amortization

     7,576        390   

Deferred tax provision

     920        1,596   

Stock compensation

     292        357   

Defined benefit plan expense

     (105     75   

Acquisition transaction expenses

     —          3,754   

Gai on revaluation of financial derivatives

     (2,471     —     

Loss on equity investment

     198        —     

Gain on sale of property, plant and equipment

     (8     —     

Provision for doubtful accounts

     523        —     

Excess tax benefit from equity awards

     (459     —     

Changes in operating assets and liabilities:

    

Accounts receivable

     (6,104     (6,722

Inventory

     (2,498     (500

Prepaid expenses and other assets

     (1,659     (182

Accounts payable

     581        4,062   

Accrued liabilities

     3,737        (101
  

 

 

   

 

 

 

Net cash provided by operating activities

     6,788        2,063   

Investing Activities:

    

Distribution paid to non-controlling interest

     (173     —     

Maturities of short-term investments

     —          9,761   

Acquisition transaction costs

     —          (699

Cash restricted for acquisition

     —          (182,002

Proceeds from the sale of property, plant and equipment

     14        —     

Purchase of property and equipment

     (3,029     (696

Loan to equity investment

     (350     —     

Patent costs

     (336     (418
  

 

 

   

 

 

 

Net cash used in investing activities

     (3,874     (174,054

Financing Activities:

    

Revolving note borrowings

     —          19,011   

Borrowing of debt

     41        68,000   

Repayments of debt

     (3,613     —     

Cash paid for financing costs

     —          (3,890

Proceeds from the sale of Series C Convertible Preferred Stock

     —          64,514   

Proceeds from the sale of embedded derivatives

     —          2,610   

Excess tax benefit from equity awards

     459        —     

Proceeds from non controlling interest

     75,547        —     

Cash paid to Series C Preferred Stock Holders

     (55     —     

Proceeds from the exercise of Common Stock options

     271        632   
  

 

 

   

 

 

 

Net cash provided by financing activities

     72,650        150,877   
  

 

 

   

 

 

 

Foreign currency effect

     1,198        1,114   
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     76,762        (20,000

Cash and cash equivalents at beginning of period

     23,839        26,584   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 100,601      $ 6,584   
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

    

Cash paid for taxes

   $ 536      $ —     
  

 

 

   

 

 

 

Cash paid for interest

   $ 874      $ 6   
  

 

 

   

 

 

 

Supplemental disclosure of non-cash transactions:

    

Issuance of Common Stock for Series C Preferred Stock redemption

   $ 7,780      $ —     
  

 

 

   

 

 

 

Issuance of Common Stock for Series C Preferred Stock dividend

   $ 1,030      $ —     
  

 

 

   

 

 

 

Common stock issued to Board of Directors and employees

   $ 147      $ —     
  

 

 

   

 

 

 

# # # #